
Today, we have approved the first treatment shown to help people with an infantile onset form of Niemann-Pick disease type C (NPC) live longer. Approved for adults and children weighing ≥7 kg (about 15 pounds) whose neurological symptoms began before age 6, the approval of this new treatment marks an important milestone for the rare disease community. fda.gov/news-events/press-an…


















